Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Genscript Corporation SARS-CoV-2 Spike protein RBD-H
Supplier: Genscript Corporation Z0374120
BA 2 differs from BA 1 in its genetic sequence including some amino acid differences in the spike protein and other proteins Studies have shown that BA 2 has a growth advantage over BA 1 Studies are ongoing to understand the reasons for this growth advantage but initial data suggest that BA 2 appears inherently more transmissible than BA 1 which currently remains the most common Omicron sublineage reported This difference in transmissibility appears to be much smaller than for example the difference between BA 1 and Delta Further although BA 2 sequences are increasing in proportion relative to other Omicron sublineages (BA 1 and BA 1 1) there is still a reported decline in overall cases globally
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction